FDA Panel to Vote on Updated Strep pneumoniae Vaccine

Courtesy MedPage Today Infectious Disease  Tue, 11/17/2009 - 11:11

WASHINGTON (MedPage Today) -- A Food and Drug Administration (FDA) advisory panel will decide Wednesday whether to recommend approval of a new version of the popular Streptococcus pneumoniae children's vaccine Prevnar.


 

More related items

FDA Panel Considers New Cell-Based Flu Vaccine
BETHESDA, Md. (MedPage Today) -- A Food and Drug Administration (FDA) panel is considering approval of the nation's first cell-based influenza vaccine -- an alternative to vaccines produced...

FDA Panel Votes in Favor of New Strep pneumoniae...
BETHESDA, Md. — A Food and Drug Administration (FDA) advisory panel has voted to recommend approval of an updated version of the Streptococcus pneumoniae vaccine Prevnar.

FDA Unveils New Safety Plan for Medical Imaging
WASHINGTON (MedPage Today) -- The Food and Drug Administration (FDA) announced it plans to issue new safety requirements for manufacturers of CT and fluoroscopic devices to reduce unnecessary...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com